Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soft part sarcomas--metastases

J B Putnam1

  • 1Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, USA.

Chest Surgery Clinics of North America
|March 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction.

The Journal of thoracic and cardiovascular surgery·2005
Same author

Induction treatment before surgery for non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2004
Same author

Resection of advanced thoracic malignancies requiring cardiopulmonary bypass.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2002
Same author

Oncodiagnosis panel: 1999. Cancer of the lung: oncodiagnosis.

Radiographics : a review publication of the Radiological Society of North America, Inc·2001

Resecting pulmonary metastases is safe and improves long-term survival. Complete tumor removal is key for better outcomes, with prognostic factors aiding treatment decisions for lung metastases.

Area of Science:

  • Oncology
  • Thoracic Surgery

Background:

  • Pulmonary metastases significantly impact patient prognosis.
  • Surgical resection is a potential treatment modality for lung metastases.

Purpose of the Study:

  • To evaluate the safety and efficacy of pulmonary metastasectomy.
  • To identify prognostic factors influencing survival after resection.

Main Methods:

  • Review of existing literature on pulmonary metastasectomy.
  • Analysis of survival data based on resection completeness and histology.

Main Results:

  • Complete resection of pulmonary metastases is associated with improved survival.
  • Histology does not negate the survival benefit of complete resection.

Related Experiment Videos

  • Prognostic indicators can guide treatment selection.

    • Conclusions:

    • Pulmonary metastasectomy is a safe procedure with potential for long-term survival.
    • Complete resection is crucial for optimizing outcomes in patients with lung metastases.
    • Future research into novel therapies may further improve survival rates.